Are We Ready for Newborn Genetic Screening? A Cross-Sectional Survey of Healthcare Professionals in Southeast China

Xian Wu, Yuqi Yang, Lingna Zhou, Wei Long, Bin YuFrontiers in Pediatrics 2022 · DOI

TL;DR

This study surveyed healthcare professionals in China about newborn genetic screening (nGS), finding strong interest and a belief in its necessity. However, a significant barrier to clinical implementation is the perceived lack of genetic counseling capacity. Education level, institution type, and prior experience with traditional screening methods were key factors influencing attitudes and knowledge.

What Problem Does This Paper Address?

Newborn screening (NBS) is a critical public health initiative that has evolved significantly with advances in DNA sequencing. Newborn genetic screening (nGS), utilizing technologies like next-generation sequencing (NGS), promises to expand the range of detectable genetic diseases beyond traditional biochemical methods. However, the widespread adoption of nGS faces numerous challenges, including technological standardization, defining screening scope, cost, and crucially, the capacity of healthcare professionals to handle the complex genetic information generated and provide adequate genetic counseling. This paper addresses the gap in understanding the readiness of healthcare professionals in China for nGS, specifically their knowledge, attitudes, willingness, and abilities, to inform its future implementation.

Methods

The researchers conducted a cross-sectional online survey of healthcare professionals working in NBS centers across six provinces in Southeast China. The survey was administered via the WJX platform, with participants accessing it by scanning a QR code. The questionnaire comprised four sections and 27 questions, covering demographic characteristics, attitudes toward nGS, knowledge of nGS technologies and principles, and ethical concerns. Data analysis involved descriptive statistics and chi-square tests to compare groups, with odds ratios and 95% confidence intervals calculated using univariate regression analysis.

Datasets

Not discussed in the paper. The study utilized a custom-designed questionnaire administered online.

Key Insights and Ideas

  • Strong Support, Significant Hurdle: While the vast majority of healthcare professionals surveyed are enthusiastic about nGS and believe it's necessary for China, the lack of genetic counseling capacity is a major concern that could impede its clinical integration.
  • Education Matters: Higher levels of education and working in more advanced institutions correlate with greater interest in nGS and a clearer understanding of suitable technologies. This suggests a need for targeted educational initiatives.
  • Experience Breeds Confidence (and Caution): Centers already engaged in traditional tandem mass spectrometry (TMS) screening showed staff who were more convinced of nGS's advantages. However, these experienced professionals were also more cautious about the appropriate population for nGS, suggesting a nuanced understanding of its implications.
  • NGS Panel Preferred: Healthcare professionals in China lean towards NGS panel sequencing over whole-genome sequencing (WGS) or whole-exome sequencing (WES) for nGS, likely due to a balance of technical feasibility, cost, and perceived effectiveness for screening serious genetic diseases.
  • Integrated Approach Favored: A significant portion of participants favored a combined screening mode where nGS and traditional TMS screening are integrated, rather than operating independently. This reflects a desire for a comprehensive and efficient screening process.

Key Results

  • Interest and Necessity: 81.01% of participants were interested in nGS, and 97.67% considered it necessary for China.
  • Perceived Advantages: 89.53% believed nGS could effectively expand the range of screened diseases, and 83.33% thought it could clarify ambiguous results and guide treatment.
  • Primary Concerns: The biggest concerns were the "great challenge to clinical counseling ability because of too much genetic information" (72.87%) and "lack of treatment interventions of screening diseases" (71.71%).
  • Suitable Technology: NGS panel sequencing was the most frequently chosen suitable technology (43.89%).
  • Application Mode: A united screening mode combining nGS and TMS was favored by 55.34% of participants.
  • Suitable Population: 58.02% believed nGS could be applied to all newborn populations, though a smaller percentage (4.58%) specifically identified NICU infants as suitable.
  • Influencing Factors: Level of education, institution level, and prior engagement in TMS screening were identified as significant influencing factors on attitudes and knowledge.

Limitations and Future Work

The authors acknowledge several limitations:

  • Geographic Scope: While covering six provinces, the number of valid questionnaires from some provinces was insufficient, potentially limiting generalizability.
  • Questionnaire Optimization: The questionnaire's validity has been demonstrated, but further optimization might be beneficial.
  • Cross-Sectional Design: This study provides a snapshot in time and cannot establish causal relationships.

Future work could focus on:

  • Addressing Genetic Counseling: Developing strategies and training programs to enhance genetic counseling capacity is paramount for clinical implementation.
  • Population Suitability: Further research is needed to clarify the most appropriate populations for nGS, especially considering the findings regarding NICU infants.
  • Technological Choices: Continued exploration of the optimal NGS technologies (e.g., panel vs. WES/WGS) for different contexts and populations is necessary.
  • Longitudinal Studies: Understanding the long-term implications and evolving attitudes towards nGS would benefit from longitudinal research.

Summary updated

Abstract

Most participants were interested and considered nGS necessary. The inability to provide genetic counseling may be the primary impediment to clinical practice. Three important influencing factors were level of education, institution level, and engagement in TMS screening.
BibTeX
@inproceedings{wu2022are,
  author = {Xian Wu and Yuqi Yang and Lingna Zhou and Wei Long and Bin Yu},
  title = {{Are We Ready for Newborn Genetic Screening? A Cross-Sectional Survey of Healthcare Professionals in Southeast China}},
  booktitle = {Frontiers in Pediatrics},
  year = {2022},
  doi = {10.3389/fped.2022.875229},
}
Figure